FDA approves Gilead’s twice-yearly HIV prevention injection, offering a powerful and convenient new option

In this article GILD Follow your favorite stocksCREATE FREE ACCOUNT The logo of Gilead Sciences pharmaceutical company is seen in Oceanside, California, April 29, 2020. Mike Blake | Reuters The Food and Drug Administration on Wednesday approved Gilead’s twice-yearly antiviral injection for preventing HIV – a milestone that the company and some experts say could…

Read More

Here’s how the stock market tends to react to Fed decisions — and how a twist this week could change that

William Watts is MarketWatch markets editor. In addition to managing markets coverage, he writes about stocks, bonds, currencies and commodities, including oil. He also writes about global macro issues and trading strategies. During his time at MarketWatch, Watts has served in key roles in the Frankfurt, London, New York and Washington, D.C., newsrooms. Adblock test…

Read More